5 Aminolevulinic Acid

DRUG3 trials

Sponsors

The department of surgery, Institute of gastroenterology, Tokyo Medical University Hospital, Alpheus Medical, Inc., Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

Conditions

5-aminolevulinic AcidColorectal cancerHigh Grade GliomaMalignant Glioma of Brain

Phase 1

The study on laparoscopic diagnosis of peritoneal dissemination of colorectal cancer with 5-aminolevulinic acid

Active, not recruitingJPRN-UMIN000030531

The department of surgery, Institute of gastroenterology, Tokyo Medical University HospitalColorectal cancer

Start: 2017-12-18Target: 40Updated: 2026-06-29

Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma

CompletedNCT05362409

Alpheus Medical, Inc.High Grade Glioma

Start: 2022-06-29End: 2025-02-03Updated: 2025-06-19

Phase 3

Photodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic Acid（5-ALA）

CompletedNCT06417281

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.5-aminolevulinic Acid, Malignant Glioma of Brain

Start: 2024-06-19End: 2025-08-19Updated: 2026-03-06

Related Papers

CTNI-18. RESULTS FROM A PHASE 1 STUDY OF SONODYNAMIC THERAPY WITH WHOLE HEMISPHERIC LOW INTENSITY NON-ABLATIVE ULTRASOUND IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA

Neuro-Oncology2024-11-012 citations

Photodynamic Diagnosis of Peritoneal Dissemination of Colorectal Cancer Using 5-Aminolevulinic Acid during Laparoscopic Surgery

SHILAP Revista de lepidopterología2021-03-01